SlidesetHIVHIV DART and Emerging Viruses 2018Hispanic/Latino longitudinal cohort of HIV-seropositive women and neurological complications | Loyda Melendez, PhDView Slideset
MAMichael AboudMBChBSlidesetHIVHIV DART and Emerging Viruses 2018Abstract: Initial viral load decline and response rates by baseline viral load strata with dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: Pooled results from the GEMINI studies (#7) | Michael AboudView Slideset
SlidesetHIVHIV DART and Emerging Viruses 2018Abstract: Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in a rapid initiation model of care for HIV-1 infection: Week 24 interim analysis of the DIAMOND study (#6) | Keith Dunn, PharmD, BCPS, AAHIVEView Slideset
SlidesetHIVHIV DART and Emerging Viruses 2018Abstract: Prevalence of neuropsychiatric conditions among HIV positive compared to HIV negative commercially insured individuals in 2017 NAFLD with dyslipidemia (#5) | Joshua Cohen, PhDView Slideset
VideoOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018Targeted agents and monoclonal antibodies | Joseph Ciccolini, PharmD, PhDView Video
VideoOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018Cytotoxic agents | Markus Jörger, MD, PhDView Video
HGHoward GurneyMBBS, FRACPVideoOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018Rationale for selecting combinations with immunotherapy | Howard Gurney, MBBS, FRACPView Video
VideoOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018Immunotherapy of prostate cancer and urothelial cancer. Future directions | Winald GerritsenView Video
VideoOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018Drug-drug interaction management with DDI-Predictor | Michel Tod, PharmD, PhDView Video
VideoOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018Pharmacotherapy of Comorbities: Cancer Patients with HIV/AIDS | Michelle Rudek, PharmD, PhDView Video
RMRon MathijssenMD, PhDVideoOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018Drug-Drug interactions with targeted oncolytics (in particular PPIs and TKIs) | Ron MathijssenView Video
